Trial Details
COMPLETEDBasic Information
| Clinical ID | c3571 |
|---|---|
| Identifier | NCT01844180 |
| Trial Title | A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome (IBS) |
| Interventions | DRUG: ONO-2952|DRUG: ONO-2952 Matching Placebo |
Participant Information
| Sponsor | Ono Pharma USA Inc |
|---|---|
| City | Anniston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2013-04 |
|---|---|
| Primary Completion Date | 2014-07 |
| Completion Date | - |